The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
The role of CXCL family members in different diseases
Open accessAbstract
Chemokines are a large family mediating a lot of biological behaviors including chemotaxis, tumor growth, angiogenesis and so on. As one member of this family, CXC subfamily possesses the same ability. CXC chemokines can recruit and migrate different categories of immune cells, regulate tumor’s pathological behaviors like proliferation, invasion and metastasis, activate angiogenesis, etc. Due to these characteristics, CXCL subfamily is extensively and closely associated with tumors and inflammatory diseases. As studies are becoming more and more intensive, CXCLs’ concrete roles are better described, and CXCLs’ therapeutic applications including biomarkers and targets are also deeply explained. In this review, the role of CXCL family members in various diseases is summarized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Li, Y., Bian, W., Jiang, Y., Liu, D., & Shen, L. (2022) · Journal of Healthcare Engineering · doi:10.1155/2022/5430175 · Cited by 5
RetractedA guide to chemokines and their receptors
Hughes, C. E., & Nibbs, R. J. B. (2018) · The FEBS Journal · doi:10.1111/febs.14466 · Cited by 1,412
Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
van Bon, L., Affandi, A. J., Broen, J., Christmann, R. B., Marijnissen, R. J., Stawski, L., Farina, G. A., Stifano, G., Mathes, A. L., Cossu, M., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1114576 · Cited by 453
Fousek, K., Horn, L. A., & Palena, C. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107692 · Cited by 359
Xu, X., Poulsen, K. L., Wu, L., Liu, S., Miyata, T., Song, Q., Wei, Q., Zhao, C., Lin, C., & Yang, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01119-3 · Cited by 359
Wang, D., Wang, X., Si, M., Yang, J., Sun, S., Wu, H., Cui, S., Qu, X., & Yu, X. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.01.005 · Cited by 322
Liu, H., Liu, S., Li, Y., Wang, X., Xue, W., Ge, G., & Luo, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034608 · Cited by 262
Chemokines from a Structural Perspective
Miller, M., & Mayo, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102088 · Cited by 235
Guo, S., Chen, J., Chen, F., Zeng, Q., Liu, W.-L., & Zhang, G. (2021) · Gut · doi:10.1136/gutjnl-2020-321187 · Cited by 226
Islet inflammation and CXCL10 in recent-onset type 1 diabetes
Roep, B. O., Kleijwegt, F. S., Van Halteren, A. G. S., Bonato, V, Boggi, U., Vendrame, F., Marchetti, P., & Dotta, F. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.04087.x · Cited by 185
Cited by
Neutrophils and Neutrophil-Based Drug Delivery Systems in Anti-Cancer Therapy
Wahnou, H., El Kebbaj, R., Hba, S., Ouadghiri, Z., El Faqer, O., Pinon, A., Liagre, B., Limami, Y., & Duval, R. E. (2025) · Cancers · doi:10.3390/cancers17071232 · Cited by 35
STAMP: Single-cell transcriptomics analysis and multimodal profiling through imaging
Pitino, E., Pascual-Reguant, A., Segato-Dezem, F., Wise, K., Salvador-Martinez, I., Crowell, H. L., Marção, M., Ruiz, M., Courtois, E., Flynn, W. F., et al. (2025) · Cell · doi:10.1016/j.cell.2025.05.027 · Cited by 28
Fish, A., Forster, J., Malik, V., & Kulkarni, A. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.4c18845 · Cited by 20
Metadata
- Authors
- Zhou, C., Gao, Y., Ding, P., Wu, T., & Ji, G.
- Venue
- Cell Death Discovery
- Published
- 2023-07-01
- Volume
- 9
- Issue
- 1
- Pages
- 212-212
- ISSN
- 2058-7716 (ISSN-L)
- OpenAlex
- W4382796862
- Cited by
- 286
- References
- 119
- FWCI
- 29.61
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The role of CXCL family members in different diseases. https://app.cochat.ai/papers/10.1038/s41420-023-01524-9
- The paper
- Zhou, C., Gao, Y., Ding, P., Wu, T., & Ji, G. (2023). The role of CXCL family members in different diseases. Cell Death Discovery. https://doi.org/10.1038/s41420-023-01524-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.